Industry

Innovative partnership between Resilient Biotics and Cosmosid sets a new horizon in microbiome research

The two companies will work on identifying, analyzing, and understanding respiratory tract microbiome systems.

Expanding Horizons in Microbiome Therapeutics: List Biotherapeutics and Sacco System Forge Strategic Alliance

This partnership emerges as a strategic move to capitalize on the expanding global microbiome market.

Probiotics for women’s health: new evidence in post-menopausal women

Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.

The PICASSO trial: painting a new future for melanoma patients

MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.

Clinical Microbiomics acquires DNASense to expand frontier technologies

This strategic acquisition is set to reshape the landscape of microbiome research, extending its applications far beyond human health.

Innovative clinical trial targets Parkinson’s disease through intestinal microbiome study

The study seeks to identify specific microbial and metabolic markers in the small intestinal fluid and blood of PD patients, offering new avenues for therapeutic intervention.

AI and the Microbiome: Crafting the Future of Health with Evogene and Verb Biotics

Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.

Novonesis: a new dawn for global biosolutions

Novozymes and Chr. Hansen have successfully merged to form Novonesis, heralding a new chapter in sustainable business practices and environmental stewardship.

QIAGEN and Penn State forge pioneering alliance to advance microbiome sciences

Underpinning this partnership is a shared vision championed by both entities, emphasizing the interconnectedness of human, animal, and ecosystem health—a concept central to the 'One Health' approach.

Explore the latest update from SynBalance on the gut-skin axis

Join SynBalance, platinum sponsor at Probiota Global 2024 (7-9 February, Milan), and discover the newst scientific data on ProBeautyShield, the probiotic ingredient designed for skin health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top